financetom
Business
financetom
/
Business
/
Viavi Snaps Up Spirent's High-Speed Ethernet Unit, Expanding AI & Security Reach
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Viavi Snaps Up Spirent's High-Speed Ethernet Unit, Expanding AI & Security Reach
Mar 3, 2025 3:25 AM

Keysight Technologies Inc. ( KEYS ) shares are trading higher premarket on Monday after the company entered into a definitive agreement to sell Spirent Communications plc’s High-Speed Ethernet and Network Security business to Viavi Solutions Inc. ( VIAV ) .

The transaction includes a base cash consideration of $410 million, with an additional contingent payment of $15 million at closing, subject to standard adjustments and conditions.

Notably, Wells Fargo has committed to providing a $425 million Term Loan B to support the financing of the transaction.

In March 2024, the boards of Spirent and Keysight ( KEYS ) agreed on the terms and conditions of a recommended all-cash acquisition of Spirent to be effected through a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006. 

The acquisition remains contingent on regulatory approvals and is anticipated to be finalized in the second quarter of 2025, following the completion of Keysight’s acquisition of Spirent.

Keysight ( KEYS ) anticipates that the sale will be finalized soon after the Spirent acquisition is completed.

This acquisition strengthens VIAVI’s Ethernet testing platform by integrating complementary capabilities while adding valuable expertise in software, hardware, and protocol domains across network layers. It positions VIAVI to expand its presence in the growing markets of Ethernet, security, AI, and digital infrastructure.

The acquisition is projected to contribute around $180 million to VIAVI’s NSE revenue within the first year post-closing and is expected to be accretive to EPS within 12 months.

VIAVI plans to leverage its U.S. net operating losses to reduce the combined company’s blended non-GAAP tax rate.

Oleg Khaykin, President and CEO of VIAVI said, “This transaction brings to VIAVI an advanced ethernet test and security product portfolio in the NEMs, Enterprise, Service Providers, Data Center Ecosystem and Government segments.”

As of December 28, 2024, VIAVI’s cash and cash equivalents stood at $512.8 million.

In a separate release, Keysight ( KEYS ) disclosed a strategic partnership with Aalyria to aid the development and validation of 5G Non-Terrestrial Networks (NTN).

As per the deal, the companies will integrate Aalyria’s AI-powered Spacetime platform with Keysight’s NTN RAN RICtest solutions.

This collaboration will provide a benchmark testbed for NTN constellation design, enabling real-world simulations and intelligent optimization of spectrum, power, beams, and beam-hopping across satellite and terrestrial networks.

Price Action: KEYS shares are up 1.67% at $162.20 premarket at the last check Monday.

Read Next:

Viavi Solutions Recovery Well Underway, Analyst Upgrades Stock, Forecasts Stronger 2025

Image via Shutterstock.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Western Digital Expands SIT Lab For AI Boom
Western Digital Expands SIT Lab For AI Boom
Oct 13, 2025
Western Digital Corporation ( WDC ) shares are trading higher on Monday. The company announced the opening of its expanded System Integration and Test (SIT) Lab. The lab, spanning a 25,600-square-foot facility, is designed to accelerate customer adoption and deliver faster time-to-value. WDC is demonstrating strength. Get the inside scoop here. The new lab addresses growing AI storage demands by...
Abeona's Gene Therapy for Rare Eye Disease Selected for FDA Pilot Program
Abeona's Gene Therapy for Rare Eye Disease Selected for FDA Pilot Program
Oct 13, 2025
10:34 AM EDT, 10/13/2025 (MT Newswires) -- Abeona Therapeutics ( ABEO ) said Monday its experimental gene therapy ABO-503 was accepted into the US Food and Drug Administration' Rare Disease Endpoint Advancement Pilot Program, which aims to speed up development of treatments for rare conditions. ABO-503 targets X-linked retinoschisis, a genetic eye disease that affects retinal structure and function. The...
Datavault AI Buys NYIAX To Fuse AI And Blockchain
Datavault AI Buys NYIAX To Fuse AI And Blockchain
Oct 13, 2025
Datavault AI Inc. ( DVLT ) said it will acquire NYIAX Inc. in a deal that combines AI-based data monetization with blockchain-powered trading. The transaction, pending approval from Nasdaq and shareholders, will add NYIAX’s exchange technology and patents to Datavault AI’s portfolio. The move follows an earlier licensing deal for NYIAX’s ADIO ultrasonic technology, which is now being fully integrated...
Pacific Biosciences Says HiFi Technology Selected for South Korean Pangenome Project
Pacific Biosciences Says HiFi Technology Selected for South Korean Pangenome Project
Oct 13, 2025
10:33 AM EDT, 10/13/2025 (MT Newswires) -- Pacific Biosciences of California ( PACB ) said Monday that its HiFi sequencing technology has been selected as the primary platform for South Korea's pangenome reference project. The company said it will provide integrated sequencing services across the workflow under the project, an initiative led by Korea National Institute of Health to sequence...
Copyright 2023-2026 - www.financetom.com All Rights Reserved